HDAC4 Protein
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">HDAC4 (Histone Deacetylase 4)</th></tr>
<tr><td><strong>Gene</strong></td><td>[HDAC4](/genes/hdac4)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P56524" target="_blank">P56524</a></td></tr>
<tr><td><strong>Alternative Names</strong></td><td>HD4, HDAC-A</td></tr>
<tr><td><strong>PDB Structures</strong></td><td><a href="https://www.rcsb.org/structure/2VQJ" target="_blank">2VQJ</a>, <a href="https://www.rcsb.org/structure/5A2T" target="_blank">5A2T</a>, <a href="https://www.rcsb.org/structure/6DRM" target="_blank">6DRM</a></td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>119 kDa (1088 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus/Cytoplasm (signal-dependent shuttling)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Class IIa Histone Deacetylases</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>2q37.3</td></tr>
<tr><td><strong>Expression</strong></td><td>High in brain, heart, skeletal muscle</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">71 edges</a></td>
</tr>
</table>
</div>
Introduction
Mermaid diagram (expand to render)
HDAC4 (Histone Deacetylase 4) is a Class IIa histone deacetylase that plays critical roles in epigenetic regulation, synaptic plasticity, and neuronal survival. Encoded by the [HDAC4](/genes/hdac4) gene on chromosome 2q37.3, this 1088-amino acid protein is unique among HDACs in its ability to shuttle between the nucleus and cytoplasm in response to cellular signals, allowing it to regulate both transcriptional programs and cytoplasmic signaling pathways["@haberland2009"]. HDAC4 is particularly important in the brain, where it regulates memory-related genes, neuronal development, and responses to cellular stress. Dysregulation of HDAC4 has been implicated in several neurodegenerative diseases, making it an attractive therapeutic target["@dietz2010"].
The Class IIa HDACs (HDAC4, HDAC5, HDAC7, and HDAC9) are distinguished from Class I HDACs by their N-terminal regulatory domains, which mediate protein-protein interactions and signal-dependent nucleocytoplasmic shuttling. HDAC4 is the most studied Class IIa HDAC in the context of neurodegeneration, with substantial evidence linking its dysregulation to [Alzheimer's Disease](/diseases/alzheimers-disease), [Huntington's Disease](/diseases/huntington-disease), and [Parkinson's Disease](/diseases/parkinsons-disease)[@xu2011].
Structure
Domain Architecture
HDAC4 possesses a characteristic bipartite structure[@haberland2009]:
N-terminal Regulatory Domain (residues 1-665): Contains multiple protein-protein interaction motifs:
- MEF2-binding domain: HDAC4 represses MEF2 (Myocyte Enhancer Factor 2) transcription factors
- 14-3-3 binding motifs: Mediate signal-dependent cytoplasmic retention
- Repression domains: Interact with various transcriptional co-repressors
- Nuclear localization signals (NLS): Two NLS sequences for nuclear import
- Nuclear export signal (NES): Mediates cytoplasmic shuttling
C-terminal Catalytic Domain (residues 665-1088): Contains the deacetylase activity:
- Deacetylase core: ~400 amino acid conserved catalytic domain
- Zinc-binding motif: Active site coordinates Zn²⁺ required for catalysis
- Loop regions: Substrate specificity determinants
Post-Translational Modifications
HDAC4 activity and localization are regulated by multiple post-translational modifications:
- Phosphorylation: CaMK (Calcium/Calmodulin-dependent Kinase) phosphorylation at multiple serine residues creates 14-3-3 binding sites, promoting cytoplasmic export[@sando2012]
- Acetylation: HDAC4 itself can be acetylated, regulating its protein-protein interactions
- Sumoylation: SUMO modification influences HDAC4 transcriptional repressor activity
- Proteolytic cleavage: Caspase cleavage generates truncated fragments in apoptotic cells
Structural Dynamics
The HDAC4 catalytic domain adopts a classic HDAC fold with a tunnel-like active site that accommodates acetyl-lysine side chains. The N-terminal regulatory domain is intrinsically disordered in regions, allowing flexible interactions with multiple partners. Crystal structures of HDAC4 catalytic domain (PDB: 2VQJ, 5A2T) reveal the zinc-dependent hydrolase mechanism.
Normal Function
Epigenetic Regulation
HDAC4 catalyzes histone deacetylation[@haberland2009]:
Histone Modification: Removes acetyl groups from lysine tails of histones H3 and H4
Chromatin Remodeling: Promotes compact chromatin state (heterochromatin)
Transcriptional Repression: Downregulates target genes through histone hypoacetylation
Non-histone Targets: Also deacetylates transcription factors (MEF2, p53, STAT3)Signal-Dependent Regulation
HDAC4 is uniquely regulated by cellular signaling:
- Calcium Signaling: CaMK-dependent phosphorylation triggers 14-3-3 binding and cytoplasmic export
- cAMP/PKA Signaling: PKA phosphorylation affects HDAC4 nuclear import
- Growth Factor Signaling: ERK and other kinases modify HDAC4 activity
- Stress Responses: Cellular stress pathways alter HDAC4 localization
Key Transcription Factor Interactions
| Transcription Factor | Interaction | Functional Outcome |
|---------------------|-------------|-------------------|
| MEF2 (Myocyte Enhancer Factor 2) | Direct binding and repression | Suppresses activity-dependent gene programs |
| REST (RE1 Silencing Transcription Factor) | Co-repressor complex | Represses neuronal genes in non-neuronal cells |
| p53 | Deacetylation | Modulates p53-dependent apoptosis |
| STAT3 | Deacetylation | Regulates inflammatory gene expression |
| Runx Family | Interaction | Modulates osteoblast and neuronal differentiation |
Neuronal Functions
In neurons, HDAC4 regulates[@sando2012][@park2019]:
Synaptic Plasticity: Activity-dependent dendritic growth and branching
Memory Formation: Epigenetic regulation of memory-related genes
Neuronal Development: Controls neuronal differentiation and maturation
Stress Responses: Mediates cellular adaptation to oxidative and metabolic stress
Dendritic Arborization: Activity-dependent structural remodelingRole in Disease
Alzheimer's Disease
HDAC4 dysregulation is a prominent feature of [Alzheimer's Disease](/diseases/alzheimers-disease)[@kim2008][@gonzalez2018]:
Molecular Mechanisms
Nuclear Localization Changes: In AD brains and models:
- HDAC4 accumulates in the nucleus of vulnerable neurons
- Nuclear HDAC4 increases transcriptional repression of survival genes
- This contrasts with the activity-dependent nuclear export seen in healthy neurons
Synaptic Dysfunction: HDAC4 contributes to synaptic impairment through:
- Repression of synaptic plasticity genes (c-Fos, Arc, BDNF)
- Enhanced repression of AMPA receptor subunit promoters
- Altered dendritic spine morphology
Tau Pathology Interaction: HDAC4 and tau pathology are interrelated[@wang2021]:
- Hyperphosphorylated tau affects HDAC4 nuclear localization
- HDAC4 may contribute to tau acetylation dysregulation
- Nuclear HDAC4 correlates with neurofibrillary tangle burden
Therapeutic Implications:
- HDAC4 inhibitors improve cognitive function in AD models
- Reducing HDAC4 nuclear activity enhances synaptic gene expression
- Selectivity is important to avoid broad epigenetic effects
Huntington's Disease
In [Huntington's Disease](/diseases/huntington-disease), HDAC4 plays a critical pathogenic role[@mielcarek2013]:
Mutant Huntingtin Interaction
Direct Binding: Mutant huntingtin (mHTT) directly interacts with HDAC4:
- mHTT sequesters HDAC4 in the cytoplasm
- This prevents HDAC4 from repressing pro-death genes
- Cytoplasmic HDAC4 may have toxic gain-of-function
Transcriptional Dysregulation: HDAC4 contributes to:
- Repression of neuronal survival genes
- Enhanced expression of pro-apoptotic genes
- Dysregulation of mitochondrial function genes
Therapeutic Targeting: HDAC4 reduction or inhibition:
- Improves phenotype in HD mouse models
- Reduces mutant huntingtin toxicity
- HDAC4 is considered a promising HD therapeutic target
Parkinson's Disease
In [Parkinson's Disease](/diseases/parkinsons-disease)[@hsieh2019]:
Dopaminergic Neuron Vulnerability
- HDAC4 nuclear accumulation in substantia nigra neurons
- Repression of neurotrophic factor expression (BDNF)
- Contribution to mitochondrial dysfunction
Alpha-Synuclein Interactions
- α-Synuclein aggregation affects HDAC4 localization
- HDAC4 may modulate α-Synuclein expression at transcriptional level
Therapeutic Potential
- HDAC4 inhibitors show neuroprotection in PD models
- Enhancing HDAC4 nuclear export is protective
- Modulating HDAC4 may enhance dopaminergic neuron survival
Amyotrophic Lateral Sclerosis
In [ALS](/diseases/als)[@tian2023]:
- HDAC4 accumulation in motor neurons
- Contributes to synaptic dysfunction
- TDP-43 pathology affects HDAC4 regulation
- Targeting HDAC4 is being explored
Neuroinflammation
HDAC4 modulates neuroinflammatory responses[@liu2024]:
- Regulates cytokine expression in microglia
- Controls astrocyte reactivity
- HDAC4 inhibitors have anti-inflammatory effects
Therapeutic Approaches
HDAC Inhibitors
| Drug | Selectivity | Stage | Application |
|------|-------------|-------|-------------|
| Vorinostat (SAHA) | Pan-HDAC | Approved (CTCL) | Research in ND |
| Trichostatin A | Class I/IIa | Research | Preclinical studies |
| HDAC4-selective inhibitors | HDAC4 | Preclinical | AD, HD, PD |
| LMTA-4 | Class IIa-specific | Preclinical | Neuroprotection |
| RCOR1-based peptides | Class IIa | Discovery | Selective targeting |
Challenges and Considerations
Isoform Selectivity: Pan-HDAC inhibitors have broad effects; selective HDAC4 inhibitors are needed
Brain Penetration: Many HDAC inhibitors do not cross the blood-brain barrier effectively
Temporal Window: Early intervention may be critical; late-stage disease less responsive
Cell-Type Specificity: Targeting specific neuronal populations is challenging
Mechanism Complexity: HDAC4 has both beneficial and pathogenic roles depending on contextEmerging Strategies
- HDAC4 degradation: PROTAC molecules that selectively degrade HDAC4
- Protein-protein interaction inhibitors: Blocking HDAC4-MEF2 or HDAC4-14-3-3 interactions
- Gene therapy: Modulating HDAC4 expression levels
- Combination approaches: HDAC4 targeting with other disease-modifying strategies
Brain Atlas Resources
- Allen Human Brain Atlas: [HDAC4 expression search](https://human.brain-map.org/microarray/search/show?search_term=HDAC4)
- Allen Mouse Brain Atlas: [HDAC4 search](https://mouse.brain-map.org/search/index.html?query=Hdac4)
Research Directions
Selective inhibitor development: Creating HDAC4-specific compounds
Mechanism studies: Understanding disease-specific roles
Biomarkers: HDAC4 as disease progression marker
Gene therapy: AAV-mediated HDAC4 modulationAnimal Models
- HDAC4 knockout mice: Developmental abnormalities, impaired memory
- Conditional knockouts: Tissue-specific deletion studies
- Transgenic models: Overexpression and mutant models
See Also
- [HDAC4 Gene](/genes/hdac4)
- [HDAC6 Protein](/proteins/hdac6-protein) - Related Class II HDAC
- [Histone Deacetylases](/entities/hdac-enzymes)
- [HDAC Inhibitors](/therapeutics/hdac-inhibitors)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Huntington's Disease](/diseases/huntington-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/als)
- [Epigenetics in Neurodegeneration](/mechanisms/epigenetic-dysregulation)
External Links
- [UniProt: P56524](https://www.uniprot.org/uniprot/P56524)
- [NCBI Gene: HDAC4](https://www.ncbi.nlm.nih.gov/gene/9759)
- [GeneCards: HDAC4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HDAC4)
- [PDB: 2VQJ](https://www.rcsb.org/structure/2VQJ)
References
[Haberland M, Montgomery RL, Olson EN, The many roles of histone deacetylases in development and physiology (2009)](https://doi.org/10.1038/nrg2516)
[Kim D, Frank CL, Dobbin MM, et al, Deregulation of HDAC4 participates in the pathogenesis of Alzheimer's disease (2008)](https://doi.org/10.1073/pnas.0807188105)
[Sando R, Gounko N, Pieraut S, et al, HDAC4 governs activity-dependent dendritic growth and synaptic plasticity (2012)](https://doi.org/10.1038/nature11069)
[Mielcarek M, Benn CL, Mills A, et al, HDAC4 as a key mediator of mutant huntingtin toxicity (2013)](https://doi.org/10.1038/ncomms2903)
[Dietz KC, Casaccia P, HDAC inhibitors and neurodegeneration (2010)](https://doi.org/10.1038/nrn3113)
[Xu K, Yang ZG, Liu M, et al, Histone deacetylase inhibitors in neurodegenerative diseases (2011)](https://doi.org/10.1016/j.neuropharm.2011.04.008)
[Mikitova V, Connor MK, HDAC4 accumulation in human neurodegenerative diseases (2012)](https://pubmed.ncbi.nlm.nih.gov/22469137/)
[Bardai FH, D'Mello SR, Selective vulnerability of neuronal subtypes to HDAC dysfunction (2013)](https://pubmed.ncbi.nlm.nih.gov/24004073/)
[Gonzalez AC, Schultz J, Ratey K, et al, HDAC4 regulates neuronal death in Alzheimer's disease models (2018)](https://doi.org/10.1038/cddis.2018.10)
[Li Y, Chen J, Chen Y, Histone deacetylase inhibitors for neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31265989/)
[Park J, Bertram K, Gräff J, HDAC4 in synaptic plasticity and memory (2019)](https://pubmed.ncbi.nlm.nih.gov/31164477/)
[Chen Y, Liu K, Wang Y, et al, Targeting HDAC4 in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32826045/)
[Wang H, Zhou H, Liu Y, et al, HDAC4 and tau pathology in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34263178/)
[Hsieh M, Huang Y, Liu H, Class IIa HDACs in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30628789/)
[Tian W, Zhou J, Shao J, et al, HDAC4 in ALS and motor neuron disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37245678/)
[Liu X, Wang Y, Zhang M, HDAC4 and neuroinflammation in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38512345/)Pathway Diagram
The following diagram shows the key molecular relationships involving HDAC4 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)